Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nucleolin pseudogene 2 is a human pseudogene designated as NCLP2, with alternative name bA85L21.1, and is cataloged in genomic databases with NCBI Gene ID: 100379142[5][9][7]. Pseudogenes are genomic DNA sequences similar to normal genes but typically nonfunctional; they may result from gene duplication or retrotransposition and generally do not encode functional proteins[5][9]. There is no evidence that NCLP2 expresses a functional protein product, nor is it linked to any known biological processes, diseases, or drug targeting. Accordingly, NCLP2 is not considered a therapeutic target, receptor, enzyme, transporter, or similar actionable molecular entity[5][9][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nucleolin pseudogene 2 (NCLP2).